Clarity Pharmaceuticals Ltd (ASX:CU6)

Clarity Pharmaceuticals Statistics

Total Valuation

ASX:CU6 has a market cap or net worth of AUD 1.18 billion. The enterprise value is 1.10 billion.

Market Cap	1.18B
Enterprise Value	1.10B

Important Dates

The last earnings date was Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:CU6 has 371.93 million shares outstanding. The number of shares has increased by 17.15% in one year.

Current Share Class	371.93M
Shares Outstanding	371.93M
Shares Change (YoY)	+17.15%
Shares Change (QoQ)	+11.53%
Owned by Insiders (%)	15.76%
Owned by Institutions (%)	22.09%
Float	274.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	124.99
PB Ratio	13.11
P/TBV Ratio	13.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.09
EV / Sales	116.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.99

Financial Position

The company has a current ratio of 9.69

Current Ratio	9.69
Quick Ratio	9.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -54.37% and return on invested capital (ROIC) is -36.51%.

Return on Equity (ROE)	-54.37%
Return on Assets (ROA)	-33.76%
Return on Invested Capital (ROIC)	-36.51%
Return on Capital Employed (ROCE)	-76.10%
Revenue Per Employee	189,257
Profits Per Employee	-1.29M
Employee Count	50
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

In the past 12 months, ASX:CU6 has paid 416,506 in taxes.

Income Tax	416,506
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.94% in the last 52 weeks. The beta is 1.49, so ASX:CU6's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	-55.94%
50-Day Moving Average	3.46
200-Day Moving Average	3.32
Relative Strength Index (RSI)	37.05
Average Volume (20 Days)	3,941,527

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:CU6 had revenue of AUD 9.46 million and -64.30 million in losses. Loss per share was -0.20.

Revenue	9.46M
Gross Profit	9.46M
Operating Income	-69.09M
Pretax Income	-63.88M
Net Income	-64.30M
EBITDA	-68.91M
EBIT	-69.09M
Loss Per Share	-0.20

Balance Sheet

The company has 84.12 million in cash and n/a in debt, giving a net cash position of 84.12 million or 0.23 per share.

Cash & Cash Equivalents	84.12M
Total Debt	n/a
Net Cash	84.12M
Net Cash Per Share	0.23
Equity (Book Value)	90.23M
Book Value Per Share	0.28
Working Capital	90.23M

Cash Flow

In the last 12 months, operating cash flow was -54.77 million and capital expenditures -182,743, giving a free cash flow of -54.95 million.

Operating Cash Flow	-54.77M
Capital Expenditures	-182,743
Free Cash Flow	-54.95M
FCF Per Share	-0.15

Margins

Gross Margin	100.00%
Operating Margin	-730.16%
Pretax Margin	-675.05%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:CU6 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.15%
Shareholder Yield	n/a
Earnings Yield	-5.44%
FCF Yield	-4.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:CU6 has an Altman Z-Score of 77.88 and a Piotroski F-Score of 1.

Altman Z-Score	77.88
Piotroski F-Score	1